Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
Main Authors: | Matteo Centonze, Giusy Di Conza, Michael Lahn, Isabel Fabregat, Francesco Dituri, Isabella Gigante, Grazia Serino, Rosanna Scialpi, Livianna Carrieri, Roberto Negro, Elena Pizzuto, Gianluigi Giannelli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | https://doi.org/10.1186/s13046-023-02797-9 |
Similar Items
-
Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
by: Matteo Centonze, et al.
Published: (2023-08-01) -
Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors
by: M.A. Deken, et al.
Published: (2023-06-01) -
Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not
by: Xiaoyun Tang, et al.
Published: (2023-05-01) -
Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma
by: Francesco Dituri, et al.
Published: (2022-04-01) -
Laminin-332 γ2 Monomeric Chain Promotes Adhesion and Migration of Hepatocellular Carcinoma Cells
by: Rosanna Scialpi, et al.
Published: (2023-01-01)